DeepMed Research

Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

Product Feasibility of a New Silicone Hydrogel Contact Lens

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Investigational Lens
Device: Acuvue Oasys Lens
Device: Air Optix Aqua Lens

First Posted Date: 2011-03-04

Last Posted Date: 2014-04-29

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 144

Registration Number: NCT01309100

Locations: 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States

Evaluation of Two Daily Disposable Contact Lenses.

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Experimental- Soflens
Device: Marketed - Soflens

First Posted Date: 2011-02-21

Last Posted Date: 2020-10-06

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 441

Registration Number: NCT01300065

Locations: 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery

Phase 3

Terminated

Conditions: Inflammation
Pain
Cataract

Interventions: Drug: Mapracorat
Drug: Vehicle

First Posted Date: 2011-02-18

Last Posted Date: 2020-09-03

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 177

Registration Number: NCT01298752

Locations: 🇺🇸
Bausch & Lomb Incorporated, Rochester, New York, United States

Mapracorat Ophthalmic Formulation in Subjects With Allergic Conjunctivitis

Phase 2

Completed

Conditions: Conjunctivitis, Allergic

Interventions: Drug: Mapracorat
Drug: Vehicle

First Posted Date: 2011-02-03

Last Posted Date: 2020-09-04

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 236

Registration Number: NCT01289431

Locations: 🇺🇸
Bausch & Lomb, Rochester, New York, United States

Safety and Efficacy of Bepotastine Besilate Nasal Spray in the Treatment of Seasonal Allergic Rhinitis

Phase 2

Completed

Conditions: Seasonal Allergic Rhinitis

Interventions: Drug: Bepotastine Besilate Nasal Spray 4% Twice a day
Drug: Bepotastine Besilate Nasal Spray 2% Twice a day
Drug: Bepotastine Besilate Nasal Spray 3% Twice a day
Drug: Placebo Nasal Spray

First Posted Date: 2011-01-14

Last Posted Date: 2020-10-05

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 601

Registration Number: NCT01277341

Locations: 🇺🇸
ISTA Pharmaceuticals, Inc., Irvine, California, United States

Study to Evaluate a Contact Lens Lubricating and Rewetting Drop

Not Applicable

Completed

Conditions: Dry Eye

Interventions: Device: Lubricating and Rewetting Drops
Device: AMO Blink Contacts Lubricant Eye Drops

First Posted Date: 2010-12-28

Last Posted Date: 2020-09-30

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 168

Registration Number: NCT01267656

Locations: 🇺🇸
Bausch & Lomb, Rochester, New York, United States

Co-Axial Micro-Incision Versus Co-Axial Small Incision Cataract Surgery Using the Stellaris Enhancement System

Phase 4

Completed

Conditions: Cataract
Aphakia

Interventions: Procedure: Coaxial Micro-Incision Cataract Surgery
Procedure: Coaxial Small Incision Cataract Surgery

First Posted Date: 2010-12-17

Last Posted Date: 2012-02-27

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 36

Registration Number: NCT01261975

Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses

Phase 4

Terminated

Conditions: Cataract

Interventions: Device: Crystalens AO
Device: SoftPort LI61AO

First Posted Date: 2010-11-16

Last Posted Date: 2014-11-26

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 6

Registration Number: NCT01241279

Locations: 🇺🇸
Bausch & Lomb, Irvine, California, United States

Product Performance of a Daily Disposable Contact Lens

Not Applicable

Completed

Conditions: Myopia

Interventions: Device: Daily disposable cosmetic tint lens

First Posted Date: 2010-10-29

Last Posted Date: 2019-08-28

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 212

Registration Number: NCT01230554

Locations: 🇸🇬
Bausch & Lomb, Singapore, Singapore

One-Piece Hydrophobic Acrylic Intraocular Lens in Subjects Undergoing Cataract Extraction

Phase 3

Completed

Conditions: Aphakia
Cataract

Interventions: Device: enVista

First Posted Date: 2010-10-28

Last Posted Date: 2013-08-22

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 122

Registration Number: NCT01230060

Locations: 🇺🇸
Bausch & Lomb, Aliso Viejo, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy